Recruiting
Plasma and Tissue SAA1 Levels in Cancer Patients to Predict Hyperprogression of Immunotherapy
NCT06276088
- Conditions
- Biomarker, Hyperprogression, Immunotherapy
- Locations
-
- Nanfang hospital, Southern medical university Guangzhou, Guangdong, China
- Fujian Provinical Hospital Fuzhou, China
- Huizhou Central People's Hospital Huizhou, China
- Jieyang people's hospital Jieyang, China